Here are relevant reports on : agile-development-market
-
DataOps Platform Market by Offering (Platform and Services), Type (Agile Development, DevOps, and Lean Manufacturing), Deployment Mode, Vertical (BFSI, Telecommunications, and Healthcare & Life Sciences) and Region - Global Forecast to 2028
The market for DataOps platform size is projected to reach USD 10.9 billion by 2028, at a CAGR of 23.0% during the forecast period. Major vendors in the global DataOps Platform market are Microsoft (US), IBM (US), Oracle (US), AWS (US), Informatica (US), Teradata (US), Wipro (India), Accenture (Ireland), SAS Institute (US), Hitachi Vantara (US), DataKitchen (US), Atlan (Singapore), Dataiku (US), Fosfor (India), Databricks (US), StreamSets (US), Talend (US), Collibra (US), Celonis (US), BMC Software (US), Saagie (France), Composable Analytics (US), Tengu.io (Belgium), Unravel Data (US), Monte Carlo Data (US), Census (US), RightData (US), Zaloni (US), Datafold (US), DataOps.live (UK), K2view (Israel).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Project Portfolio Management Market by Software Type (Strategic Portfolio Management Software, Project, Program & Resource Management, Financial Portfolio Management, Governance, Risk & Compliance Management, Agile & Collaborative)-Global Forecast to 2031
The global project portfolio management market is expanding rapidly, with a projected market size anticipated to rise from about USD 9.79 billion in 2026 to USD 17.75 billion by 2031, featuring a CAGR of 12.6%. The key players include Planview (US), Broadcom (US), Smartsheet (US), ServiceNow (US), Microsoft (US), Oracle (US), SAP (Germany), Atlassian (Australia), Asana (US), and monday.com (Israel).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Cloud-Based Application Development Services Market : Worldwide Market Forecast and Analysis (2014-2019)
Businesses around the world are facing stiff competition with numerous players rapidly joining their respective market space. . A business entity, therefore, needs to stay ahead of the competition as well as undergo changes in accordance with the changing market dynamics. It needs to build an intelligent operational framework in order to achieve sustainability. Companies are thus moving towards custom enterprise applications to improve business performance and meet unique business requirements. Enterprises are swiftly turning to cloud technologies for various operational changes since the past six to seven years. The major reasons behind the large scale demand for cloud-based enterprise applications have been the massive scalability and reduced operational costs offered by the cloud services. The scalability and extensible architectures offered by cloud-based applications support complete business availability for global customers, as it reduces development cycles and risks to a minimum. The major service types involved in the market are application consulting, customization, testing, integration, and other services such as training, support, and maintenance. The market revenues are considered from the total application development spending over private, public, and hybrid clouds. Security considerations in the public cloud differ substantially from that in a private cloud. This factor is considered to be a major constraint for the public cloud deployment segment during the forecast.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Europe Cloud Computing Market by Service Model (IaaS [Compute, Storage, Networking], PaaS [Application Development & Integration, Database & Data Analytics & Reporting], SaaS [CRM, SCM, Collaboration & Productivity]), Impact of AI - Forecast to 2030
The market size for the cloud computing market in Europe is estimated to significantly increase from USD 325.92 billion in 2025 to USD 550.42 billion by 2030 at a CAGR of 11.0%. The major players in the Europe cloud computing market include Microsoft (US), Google (US), AWS (US), IBM (US), Oracle (US), Scaleway (France), OVHcloud (France), UpCloud (Finland), Exoscale (Switzerland), gridscale (Germany), Elastx (Sweden), IONOS (Germany), Aruba Cloud (Italy), Cyso Cloud (Netherlands), and Open Telekom Cloud (Germany).
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Real-world Evidence Solutions Market by Component [Datasets (Claims, Clinical, Pharmacy, Genomics), Application [Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement], End User (Pharma, Medtech, Payers, Provider), Region- Global Forecast to 2031
The global real-world evidence solutions market is projected to reach USD 12.44 billion by 2031, growing at a CAGR of 14.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
Records 1 to 10 of 50
